Items where Division is "Medicine > Zentren des Universitätsklinikums Regensburg > Zentrum für Hirntumore (ZHT)" and Year is 2013

H

Herrlinger, U. and Schaefer, N. and Steinbach, J. P. and Weyerbrock, A. and Hau, P. and Goldbrunner, R. and Kohnen, R. and Urbach, H. and Stummer, W. and Glas, M. (2013) Bevacizumab, irinotecan and radiotherapy versus standard temozolomide and radiotherapy in newly diagnosed, MGMT-non-methylated glioblastoma patients: Updated results from the randomized multicenter GLARIUS trial. ELSEVIER SCI LTD, OXFORD.

Herrlinger, Ulrich and Schaefer, Niklas and Steinbach, Joachim Peter and Weyerbrock, Astrid and Hau, Peter and Goldbrunner, Roland and Friedrich, Franziska and Stockhammer, Florian and Ringel, Florian and Braun, Christian and Kohnen, Ralf and Leutgeb, Barbara and Belka, Claus and Urbach, Horst and Stummer, Walter and Glas, Martin (2013) Bevacizumab, irinotecan, and radiotherapy versus standard temozolomide and radiotherapy in newly diagnosed, MGMT-non-methylated glioblastoma patients: First results from the randomized multicenter GLARIUS trial. JOURNAL OF CLINICAL ONCOLOGY, 31 (15supp): LBA2000. ISSN 0732-183X, 1527-7755

R

Riemenschneider, Markus J. and Louis, David N. and Weller, Michael and Hau, Peter (2013) Refined brain tumor diagnostics and stratified therapies: the requirement for a multidisciplinary approach. SPRINGER, NEW YORK.

S

Stupp, Roger and Hegi, Monika E. and Goriia, Thierry and Erridge, Sara and Grujicic, Danica and Steinbach, Joachim Peter and Wick, Wolfgang and Tarnawski, Rafal and Nam, Do-Hyun and Weyerbrock, Astrid and Hau, Peter and Taphoorn, Martin J. B. and Nabors, Louis B. and Reardon, David A. and Van den Bent, Martin J. and Perry, James R. and Hong, Yong Kil and Hicking, Christine and Picard, Martin and Weller, Michael (2013) Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with O-6-methylguanine-DNA methyltransferase (MGMT) promoter methylation: Final results of the multicenter, randomized, open-label, controlled, phase III CENTRIC study. JOURNAL OF CLINICAL ONCOLOGY, 31 (15supp): LBA2009. ISSN 0732-183X, 1527-7755

T

Tabatabai, Ghazaleh and Wick, Wolfgang and Reifenberger, Guido and Steinbach, Joachim Peter and Schnell, Oliver and Hau, Peter and Herrlinger, Ulrich and Sabel, Michael and Ketter, Ralf and Schlegel, Uwe S. and Marosi, Christine and Goldbrunner, Roland and Homicsko, Krisztian and Nikkhah, Guido and Pichler, Josef and Vajkoczy, Peter and Meixensberger, Juergen and Weller, Michael (2013) Dose-intensified rechallenge with temozolomide: One week on/one week off versus 3 weeks on/one week off in patients with progressive or recurrent glioblastoma (DIRECTOR). JOURNAL OF CLINICAL ONCOLOGY, 31 (15supp): TPS2103. ISSN 0732-183X, 1527-7755